Skip to main content
Novartis AG logo

Novartis AG — Investor Relations & Filings

Ticker · NOVN ISIN · CH0038459415 LEI · 5493007HIVTX6SY6XD66 SW Manufacturing
Open in API
Filings indexed 1,070 across all filing types
Latest filing 2017-06-12 Director's Dealing
Country CH Switzerland
Listing SW NOVN

About Novartis AG

https://www.novartis.com/

Novartis AG is a global medicines company focused on the research, development, manufacturing, and marketing of innovative healthcare products. The company's mission is to reimagine medicine to improve and extend people's lives. By leveraging advanced science and technology, Novartis develops a portfolio of treatments across various therapeutic areas to address the evolving needs of patients and societies. The firm is committed to delivering high-value medicines that tackle some of the most challenging healthcare issues worldwide.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2017-06-12 English
FORM 4 SUBMISSION
Director's Dealing
2017-06-08 English
FORM 4 SUBMISSION
Director's Dealing
2017-06-06 English
FORM 4 SUBMISSION
Director's Dealing
2017-06-02 English
SD
Regulatory Filings Classification · 100% confidence The document is a Form SD filed with the SEC, titled 'Specialized Disclosure Report' for Novartis AG. It references Rule 13p-1 under the Securities Exchange Act, which pertains to conflict minerals disclosure. The text states that the Conflict Minerals Report is attached as an exhibit and is also publicly available on the company's website. The document is only 2430 characters long, which is quite short and primarily serves as a disclosure filing rather than a full report. Form SD filings are specialized disclosures related to conflict minerals and do not fall under typical financial reports like Annual Reports or Interim Reports. Given the nature of the filing and its content, the appropriate classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory filings that do not fit other categories.
2017-05-31 English
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by Novartis AG, a foreign private issuer, with the SEC. It is dated May 31, 2017, and provides a detailed update on the company's management event, strategic outlook, pipeline developments, and business unit performance. The content includes forward-looking statements, strategic plans, product launches, and operational updates. It is not a full annual or quarterly report, nor is it an earnings release or audit report. It is a regulatory filing used by foreign private issuers to report material information to the SEC between annual reports. The document is substantive and detailed, not merely an announcement or certification. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories but are regulatory in nature.
2017-05-31 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.